2006
DOI: 10.1016/j.micres.2005.04.004
|View full text |Cite
|
Sign up to set email alerts
|

Chlamydia trachomatis persistence: An update

Abstract: Chlamydial persistence is a reversible state generated during conditions deleterious to growth. In persistence, Chlamydia trachomatis remains viable but atypical, with an enlarged, aberrant form and quiescent metabolism. It favours chronic chlamydiosis, leading to serious sequelae. Although the mechanism of persistence formation is still unknown, more reliable molecular approaches tend to confirm that its occurs in vivo, even lasting 3 years. One approach consists of identifying unprocessed rRNA found only in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
76
1
3

Year Published

2007
2007
2017
2017

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 103 publications
(87 citation statements)
references
References 65 publications
5
76
1
3
Order By: Relevance
“…Despite appropriate drug therapy, chlamydial infections are highly likely to recur. The majority of clinical failures are due to reinfection or relapse following phenotype deviation of the bacteria to persistent, non-replicating types that are antibiotic resistant but can revert to the typical reticulate body phenotype once treatment is complete (2,3). Currently, the recommended first-line therapeutic regimen for chlamydial infections is the administration of tetracyclines and macrolides, which impede bacterial translation by binding to 30S and 50S ribosomal subunits, respectively (4).…”
Section: Introductionmentioning
confidence: 99%
“…Despite appropriate drug therapy, chlamydial infections are highly likely to recur. The majority of clinical failures are due to reinfection or relapse following phenotype deviation of the bacteria to persistent, non-replicating types that are antibiotic resistant but can revert to the typical reticulate body phenotype once treatment is complete (2,3). Currently, the recommended first-line therapeutic regimen for chlamydial infections is the administration of tetracyclines and macrolides, which impede bacterial translation by binding to 30S and 50S ribosomal subunits, respectively (4).…”
Section: Introductionmentioning
confidence: 99%
“…Even life-threatening situations have been reported in humans who became infected with zoonotic chlamydiae, such as C. psittaci originating from birds or C. abortus from small ruminants [9,12,28,54,55]. Secondly, chlamydial organisms are reported to persist and cause recurrent infections or re-activation of latent infections [7,11,25,46].…”
Section: Introductionmentioning
confidence: 99%
“…C hlamydia are obligate intracellular bacterial pathogens that cause a wide spectrum of human diseases worldwide, ranging from ocular inflammation to pneumonia to sexually transmitted diseases (1). Because of insufficient understanding of the mechanisms underlying the development of pathogenesis or host protective response to chlamydial infection, an effective human vaccine is not available at the present time.…”
mentioning
confidence: 99%